Clinical Trial Update: Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration [Phase 3]

View source ↗

Summary

The Manta Study is a Phase 3 trial comparing Avastin (bevacizumab) with Lucentis (ranibizumab) for age-related macular degeneration; the status is currently UNK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Age Related Macular Degeneration | Phase 3 | Status: UNKNOWN